Bjorn Eliasson

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi Cigarette smoking and diabetes
    Bjorn Eliasson
    Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Goteborg, Sweden
    Prog Cardiovasc Dis 45:405-13. 2003
  2. ncbi Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone
    Joakim Håkansson
    Department of Medical and Clinical Genetics, Institute of Biomedicine University of Gothenburg, Goteborg, Sweden
    Diabetol Metab Syndr 3:32. 2011
  3. ncbi The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003
    B Eliasson
    Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Goteborg, Sweden
    Diabet Med 22:1420-6. 2005
  4. ncbi Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register
    Katarina Eeg-Olofsson
    Department of Medicine, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Diabetes Care 30:496-502. 2007
  5. ncbi Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register
    B Eliasson
    Department of Medicine, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Diabetes Metab 33:269-76. 2007
  6. ncbi Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
    Katarina Eeg-Olofsson
    Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Goteborg, Sweden
    Diabetes Care 33:1640-6. 2010
  7. ncbi Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients
    K Eeg-Olofsson
    Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Goteborg, Sweden
    Diabetologia 52:65-73. 2009
  8. ncbi Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register
    Bjorn Eliasson
    Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Goteborg, Sweden
    Diabetes Care 34:2095-100. 2011
  9. ncbi Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR)
    S Gudbjornsdottir
    Department of Medicine, Sahlgrenska University Hospital, Goteborg University, Goteborg, Sweden
    Diabet Med 26:53-60. 2009
  10. ncbi Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register
    Bjorn Eliasson
    Department of Medicine, University of Gothenburg, Sahlgrenska University Hospital, Goteborg, Sweden
    PLoS ONE 6:e18744. 2011

Detail Information

Publications20

  1. ncbi Cigarette smoking and diabetes
    Bjorn Eliasson
    Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Goteborg, Sweden
    Prog Cardiovasc Dis 45:405-13. 2003
    ..In diabetes care, smoking cessation is of utmost importance to facilitate glycemic control and limit the development of diabetic complications...
  2. ncbi Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone
    Joakim Håkansson
    Department of Medical and Clinical Genetics, Institute of Biomedicine University of Gothenburg, Goteborg, Sweden
    Diabetol Metab Syndr 3:32. 2011
    ..abstract:..
  3. ncbi The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003
    B Eliasson
    Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Goteborg, Sweden
    Diabet Med 22:1420-6. 2005
    ..Thus, giving up smoking and increased use of aspirin are called for, as well as more aggressive treatment of hyperglycaemia, elevated blood pressure and blood lipid levels, in accordance with updated international guidelines...
  4. ncbi Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register
    Katarina Eeg-Olofsson
    Department of Medicine, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Diabetes Care 30:496-502. 2007
    ..This study was designed to investigate the clinical characteristics of a large type 1 diabetic population and to evaluate the degree of fulfillment of recently updated treatment goals...
  5. ncbi Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register
    B Eliasson
    Department of Medicine, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Diabetes Metab 33:269-76. 2007
    ..To describe clinical characteristics and antihyperglycemic treatment patterns in patients with varying duration of diabetes...
  6. ncbi Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
    Katarina Eeg-Olofsson
    Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Goteborg, Sweden
    Diabetes Care 33:1640-6. 2010
    ..We assessed the association between A1C and cardiovascular diseases (CVDs) in an observational study of patients with type 1 diabetes followed for 5 years...
  7. ncbi Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients
    K Eeg-Olofsson
    Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Goteborg, Sweden
    Diabetologia 52:65-73. 2009
    ..9 kg/m(2)) and obesity (BMI >or= 30 kg/m(2)) with cardiovascular disease in type 2 diabetes, as these associations have not previously been clarified...
  8. ncbi Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register
    Bjorn Eliasson
    Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Goteborg, Sweden
    Diabetes Care 34:2095-100. 2011
    ..We assessed the association between different blood lipid measures and risk of fatal/nonfatal coronary heart disease (CHD)...
  9. ncbi Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR)
    S Gudbjornsdottir
    Department of Medicine, Sahlgrenska University Hospital, Goteborg University, Goteborg, Sweden
    Diabet Med 26:53-60. 2009
    ..We aimed to examine risk factor management and control levels in a large sample of patients with Type 2 diabetes with CHD...
  10. ncbi Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register
    Bjorn Eliasson
    Department of Medicine, University of Gothenburg, Sahlgrenska University Hospital, Goteborg, Sweden
    PLoS ONE 6:e18744. 2011
    ..To describe the use and evaluate the effectiveness of different lipid lowering therapies in unselected patients with type 1 and type 2 diabetes in clinical practice...
  11. ncbi The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care
    Soffia Gudbjornsdottir
    Diabetes Centre, Sahlgrenska University Hospital, Goteborg, Sweden
    Diabetes Care 26:1270-6. 2003
    ..To monitor glycemic control, treatable risk factors, and treatment profile for quality assessment of diabetes care on a national scale...
  12. ncbi [The National Diabetes Registry 1996-2003. Quality assessment shows improved diabetic care]
    Soffia Gudbjornsdottir
    Diabetescentrum, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 101:3790, 3793-7. 2004
    ..This should imply a reduction of the risk for diabetic complications. As the national goals are still difficult to reach, individual goals should be set for the treatment...
  13. ncbi Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases
    U Smith
    The Lundberg Laboratory for Diabetes Research, The Sahlgrenska Academy at Goteborg University, Goteborg, Sweden
    J Intern Med 260:409-20. 2006
    ..The pathogenesis of the vascular complications and the current treatment regimens were discussed in relation to the history and examinations performed in these patients...
  14. ncbi New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
    K Eeg-Olofsson
    Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
    J Intern Med 268:471-82. 2010
    ..To analyse the association between glycosylated haemoglobin A1c (HbA1c) and cardiovascular disease (CVD) in patients with type 2 diabetes in the Swedish National Diabetes Register (NDR)...
  15. ncbi Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial
    B Eliasson
    Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Goteborg University, Goteborg, Sweden
    Int J Obes (Lond) 31:1140-7. 2007
    ..To examine the metabolic effects and body composition changes after topiramate treatment of obese type 2 diabetic patients (DM2) for 11 months...
  16. ncbi Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis
    B Gustafson
    The Lundberg Laboratory for Diabetes Research, Center of Excellence for Metabolic and Cardiovascular Research, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital, Blå Stråket 3, 413 45 Gothenburg, Sweden
    Diabetologia 53:536-40. 2010
    ..Previous studies have shown that treatment of type 2 diabetic patients with thiazolidinediones (TZDs) reduces bone density and increases risk of bone fractures, while body fat is increased...
  17. ncbi Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects
    T Axelsson
    Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, , Sweden
    J Intern Med 249:539-44. 2001
    ..These results show that diabetic subjects are particularly susceptible to the detrimental effects of nicotine...
  18. ncbi The insulin resistance syndrome and postprandial lipid intolerance in smokers
    B Eliasson
    Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Atherosclerosis 129:79-88. 1997
    ..The effects of cigarette smoking on insulin resistance, postprandial lipemia following a mixed meal, lipoproteins and other aspects of the insulin resistance syndrome (IRS) were investigated in healthy middle-aged men...
  19. ncbi Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes
    U Smith
    Lundberg Laboratory for Diabetes Research, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Ann N Y Acad Sci 892:119-26. 1999
    ..Thus, impaired IRS-1 expression and downstream signaling events in fat cells in response to insulin are associated with insulin resistance and Syndrome X...
  20. ncbi Endocrine abnormalities in healthy first-degree relatives of type 2 diabetes patients--potential role of steroid hormones and leptin in the development of insulin resistance
    P-A Jansson
    Lundberg Laboratory for Diabetes Research, , Sahlgrenska University Hospital, , Sweden
    Eur J Clin Invest 32:172-8. 2002
    ..Dysregulation of these hormones may be important in the development of insulin resistance and type 2 diabetes...